Oncovision, Inc.

Oncovision is a Spanish-based medical imaging company specializing in innovative diagnostic and therapeutic imaging devices for oncology, radiology, surgery, and nuclear medicine. The company develops molecular imaging solutions focused on early cancer detection and treatment planning. Primary product lines include Mammi (breast PET imaging system for breast cancer diagnosis), Sentinella (intraoperative imaging system for surgical guidance), WProbe (portable probe device for accurate, practical imaging applications), and CaremiBrain (neuroimaging application for Alzheimer's disease diagnosis). The company serves surgeons, radiologists, oncologists, and nuclear physicians. Oncovision holds recognition as an innovative SME (PYME INNOVADORA) with validity through May 2027, indicating compliance with Spanish innovation standards. The company has received funding through Generalitat Valenciana's Fondos Plan Resistir Plus and is capitalized by Innvierte, an investment initiative of Spain's CDTI (Centro para el Desarrollo Tecnológico Industrial). The organization emphasizes innovation, commitment, excellence, and continuous improvement in molecular imaging technology for cancer diagnosis and treatment.